The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Alnylam announced the FDA approval of its supplemental new drug application for vutrisiran, an RNA interfering small molecule ...

The approval expands the indication for Amvuttra, which now becomes the first and only therapeutic approved by the FDA for ...

Helios Care will once again host an event to help children deal with the loss of loved ones. Helios’ Spring Camp Forget-Me-Not will be held Saturday, May 3 in Richmondville at the Radez Elementary ...

Helios Technologies (HLIO) announced that the Board of Directors has elected Laura Dempsey Brown as the new Board Chair. Ms. Dempsey Brown, a ...

Helios Towers forecast on Thursday its adjusted core earnings would continue to rise in 2025 after the independent telecommunications infrastructure company reported a 2024 profit rise in line with ...

Helios Towers sees 10% sales growth in 2024, double-digit EBITDA gains until 2026, and an attractive valuation. Learn more ...

The UK market has been experiencing turbulence, with the FTSE 100 index closing lower due to weak trade data from China, highlighting global economic challenges. Despite these broader market concerns, ...

The Acer Predator Helios Neo 16 is a great laptop that performs exceptionally, but should not be a user’s first travel option ...

Save big on one of the fastest RTX 4080 laptops with the Acer Predator Helios 18, only for a limited time at Best Buy!

The FDA has approved a supplemental new drug application for the treatment of cardiomyopathy wild-type or hereditary transthyretin-mediated amyloidosis.